Literature DB >> 2525120

In-vitro activity of clarithromycin (A-56268; TE-031) against gram-positive bacteria.

K Rolston, G Gooch, D Ho.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2525120     DOI: 10.1093/jac/23.3.455

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  6 in total

1.  Absolute bioavailability of clarithromycin after oral administration in humans.

Authors:  S Y Chu; R Deaton; J Cavanaugh
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

2.  Comparative in vitro activity of the new erythromycin derivative dirithromycin against gram-positive bacteria isolated from cancer patients.

Authors:  K V Rolston; D H Ho; B LeBlanc; G P Bodey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-01       Impact factor: 3.267

Review 3.  Clarithromycin clinical pharmacokinetics.

Authors:  F Fraschini; F Scaglione; G Demartini
Journal:  Clin Pharmacokinet       Date:  1993-09       Impact factor: 6.447

Review 4.  Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential.

Authors:  D H Peters; S P Clissold
Journal:  Drugs       Date:  1992-07       Impact factor: 9.546

5.  Antimicrobial susceptibility, beta-lactamase and enterotoxin production in Bacillus cereus isolates from clinical and food samples.

Authors:  K Godic Torkar; K Seme
Journal:  Folia Microbiol (Praha)       Date:  2009-08-02       Impact factor: 2.099

6.  Comparative study of clarithromycin and penicillin V in the treatment of streptococcal pharyngitis.

Authors:  G E Stein; S Christensen; N Mummaw
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-11       Impact factor: 3.267

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.